These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 756665)

  • 21. A kinetic study of sulindac in the elderly.
    Bayley N; Warne RW; Moulds RF; Bury RW
    Aust N Z J Med; 1987 Feb; 17(1):39-42. PubMed ID: 3476045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biotransformation of sulindac in end-stage renal disease.
    Gibson TP; Dobrinska MR; Lin JH; Entwistle LA; Davies RO
    Clin Pharmacol Ther; 1987 Jul; 42(1):82-8. PubMed ID: 3595070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of age and disease on the pharmacokinetics and pharmacodynamics of sulindac.
    Sitar DS; Owen JA; MacDougall B; Hunter T; Mitenko PA
    Clin Pharmacol Ther; 1985 Aug; 38(2):228-34. PubMed ID: 4017423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulindac metabolism: the importance of an intact colon.
    Strong HA; Warner NJ; Renwick AG; George CF
    Clin Pharmacol Ther; 1985 Oct; 38(4):387-93. PubMed ID: 4042521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enterohepatic circulation of sulindac and metabolites.
    Dujovne CA; Pitterman A; Vincek WC; Dobrinska MR; Davies RO; Duggan DE
    Clin Pharmacol Ther; 1983 Feb; 33(2):172-7. PubMed ID: 6822030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulindac hepatotoxicity: a case report and review.
    Gallanosa AG; Spyker DA
    J Toxicol Clin Toxicol; 1985; 23(2-3):205-38. PubMed ID: 3903180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of sulindac on myeloid precursors growth in vitro.
    Torres A; Gómez P; Martínez-Sánchez F; Bayón P; Manzanares R; Prieto B
    Methods Find Exp Clin Pharmacol; 1984 Feb; 6(2):63-5. PubMed ID: 6717172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure of sulindac to increase serum lithium levels.
    Ragheb MA; Powell AL
    J Clin Psychiatry; 1986 Jan; 47(1):33-4. PubMed ID: 3941055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sparing effect of sulindac on lithium levels.
    Miller LG; Bowman RC; Bakht F
    J Fam Pract; 1989 May; 28(5):592-3. PubMed ID: 2715775
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of the antirheumatic drug Sulindac on thrombocyte function (author's transl)].
    Schenk H; Klein G; Neubauer M; Pilger E
    Wien Med Wochenschr; 1980 May; 130(10):344-9. PubMed ID: 7434788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation of methylthio metabolites of indene in the guinea pig and the rat.
    Bartels MJ; Horning EC; Horning MG
    Drug Metab Dispos; 1986; 14(1):97-101. PubMed ID: 2868872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulindac (Clinoril)--a new drug for arthritis.
    Med Lett Drugs Ther; 1979 Jan; 21(1):1-2. PubMed ID: 759836
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypertensive reaction with sulindac.
    Easton PA; Koval A
    Can Med Assoc J; 1980 Jun; 122(11):1273-4. PubMed ID: 7388724
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical development plan: sulindac.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():240-51. PubMed ID: 7616747
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on pharmacokinetics of 9 -fluorohydrocortisone in the rat, guinea pig and dog].
    Wenzl H; Garbe A; Nowak H
    Arzneimittelforschung; 1971 Aug; 21(8):Suppl:1115-22. PubMed ID: 5109326
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-steroidal anti-inflammatory agents, tolmetin and sulindac, attenuate oxidative stress in rat brain homogenate and reduce quinolinic acid-induced neurodegeneration in rat hippocampal neurons.
    Dairam A; Chetty P; Daya S
    Metab Brain Dis; 2006 Sep; 21(2-3):221-33. PubMed ID: 16850258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric acid and gastrin secretion after administration of the anti-inflammatory drug, sulindac, in man.
    Caldara R; Ferrari C; Romussi M; Grimaldi MG
    Arzneimittelforschung; 1980; 30(9):1610-1. PubMed ID: 7193033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulindac does not spare renal prostaglandins.
    Waslen TA; McCauley FA; Wilson TW
    Clin Invest Med; 1989 Apr; 12(2):77-81. PubMed ID: 2650941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulindac-derived Ras pathway inhibitors target the Ras-Raf interaction and downstream effectors in the Ras pathway.
    Waldmann H; Karaguni IM; Carpintero M; Gourzoulidou E; Herrmann C; Brockmann C; Oschkinat H; Müller O
    Angew Chem Int Ed Engl; 2004 Jan; 43(4):454-8. PubMed ID: 14735533
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative pharmacokinetics of the histamine H1-receptor antagonist ebastine and its active metabolite carebastine in rats, guinea pigs, dogs and monkeys.
    Matsuda M; Sakashita M; Mizuki Y; Yamaguchi T; Fujii T; Sekine Y
    Arzneimittelforschung; 1994 Jan; 44(1):55-9. PubMed ID: 7907872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.